Viewing Study NCT00501020


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-02-06 @ 9:55 PM
Study NCT ID: NCT00501020
Status: COMPLETED
Last Update Posted: 2017-10-09
First Post: 2007-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes View
None metformin View
None rosiglitazone View